Hybridan Small Cap Feast: 08/08/2024
* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour
Dish of the day
What’s baking in the oven? **
Banquet Buffet***
The data solutions provider announces that at its AGM at 9.00 am today, the Chairman will confirm the Group has a growing pipeline across a range of end markets and is highly confident in the Group's strategy to deliver growth in the coming years. Underpinning this has been the positive momentum the Company has been achieving with existing and new customers, and reports a recent contract win with a new customer and an upsell to an existing customer, both in the leisure and travel sector, contributing in aggregate approximately £0.7m in ARR. The new customer win is a three-year Celebrus Platform contract with a leading global airline.
A designer and manufacturer of leading-edge computer products, systems, and mission-critical solutions used in high-performance markets by some of the world's major OEMs, announces an expansion to its single largest ever contract. Further to the announcement on 20 June 2024, Concurrent Technologies has secured an additional uplift of $1.52m to its $4.46m contract with a major US Defence and Aerospace prime contractor, to supply computer plug-in-cards. The total contract value is now $5.98m. The increased order reflects the customer's trust in the reliability of the Group's products and strength of the relationship. The Company's latest product, TR MDx/6sd-RCR, announced on 29 July 2024, has been fundamental in securing this order uplift.
A clinical-stage biopharmaceutical company pursuing a clever approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, announces the appointment of Yrjö Wichmann, Faron's current interim Chief Financial Officer (CFO, int.), as the Company's permanent Chief Financial Officer (CFO). Mr. Wichmann has served as Faron's interim CFO since April 2024, having previously served as the Company's CFO between 2014 and 2019 and as Senior Vice President, Financing & IR 2019 to April 2024. He is an accomplished biotech and financial executive with over 20 years' experience in financing and investment banking.
The company that provides outsourced investment administration and settlement services announces its interim results for the six months ended 30 June 2024. Revenue decreased 12% to £6.45m (H1 2023: £7.33m), profit before tax decreased 28.9% to £2.71m (H1 2023: £3.81m) and cash and cash equivalents increased to £5.93m (H1 2023: £5.71m). Due to subdued trading volumes; the increasing costs of the Skilled Person review; the costs of the associated remediation work and the ongoing impact of the voluntary agreed restrictions (VREQ) on the Company's Model B clients, the directors anticipate that the trading for the full year ending 31 December 2024 will be significantly below market expectations.
The provider of services to the Affordable Housing sector in the UK, announces its interim financial results for the six months ended 30 June 2024. Revenues were up 10% to £580.0m (H1 2023: £525.6m), profit before tax increased by 44% to £30.5m (H1 2023: £21.2m) and average daily net cash increased 16% to £66.4m (H1 2023: £57.4m). The positive momentum in the first six months of 2024 has continued into the second half. The Board now anticipates revenue for the full year of approximately £1.1bn, with adjusted profit before tax in a range of £53m-£55m, ahead of current market expectations.
The marketing and services business focused on the UK consumer legal market, provides a trading update for the six months to 30 June 2024. The Group has traded in line with the Board's expectations. Revenues for the period are expected to be £19.4m (H1 2023: £21.0m), and operating profit is expected to be broadly in line with last year. The Group has made further progress in reducing net debt and at 30 June 2024, net debt had decreased 7% to £9.0m (31 December 2023: £9.7m). Trading through July has continued to plan and as a result, the Board remains confident of delivering a full year outturn in line with market expectations.
The oil and gas development and production company focused on oil assets in Peru, reports its operating and financial results for the three and six months ended June 30, 2024. Average Q2 2024 production and sales were 18,290 and 18,050 barrels of oil per day (bopd), respectively. The Q2 2024 EBITDA and free funds flow were $69.5m ($42.31/bbl) and $36.3m ($22.11/bbl), respectively. The Company exited Q2 2024 with a total cash of $95.9m. Q2 2024 operating and financial results were robust and Q3 and Q4 are now underpinned by strong drilling results this quarter.
The investment company focused on European gas and power projects, confirms further to the announcement on 5 August 2024 (the Retail Offer Announcement), the result of its Placing, Subscription and WRAP Retail Offer (together, the Fundraise) at the issue price of 6p per share, representing a 8% discount to closing price on 2nd August 2024. The Company has raised aggregate gross proceeds of £859,323.60 pursuant to the WRAP Retail Offer, which has been significantly oversubscribed. In total, the Placing, Subscription and WRAP Retail Offer have raised, in aggregate, gross proceeds of approximately £4.2m. The proceeds will enable Prospex to acquire 7.5% of HEI. This increased share has been made feasible from the success of the oversubscribed WRAP Retail Offer.
The advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, publishes its Key Performance Indicators (KPIs) for the quarter ended 30 June 2024. Cars on the road with Seeing Machines' technology increased to 2,211,422 units, representing an increase of 104% from 12 months ago (Q4 FY2023: 1,086,176), Quarterly production was 381,215 units, up 22% from the previous quarter and monitored guardian connections increased by 19% during the last 12 months to 62,010 units (Q4 FY2023: 51,975).
The energy company particularly focused on oil and gas exploration and production today announces that, further to its announcement of 5th August 2024, it has conditionally raised approximately £248,204 at a price of 0.05p per share pursuant to its offer to its existing retail shareholders via CMC CapX. The Issue Price represents a discount of approximately 37% to the closing price of 0.08 pence per share on 2nd August 2024. On 5th August, the Company announce that it has conditionally raised gross proceeds of £1m by means of a placing at the same issue price. The proceeds will be employed to advance the Company's hydrogen storage project.
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.